FimmCyte’s Post

FimmCyte reposted this

Would love to see many of the UZH Entrepreneur Fellowship Alumni among the TOP 100 🏆 . Join me in voting for your favorite entrepreneur 👩⚖️ 👨⚕️ ! From A to Z: Ana Montalban-Arques co-founded Recolony AG (Fellow 20’) Deana Mohr-Haralampieva co-founded MUVON Therapeutics AG (Fellow 19’) Denys Sutter co-founded condenZero (Fellow 19’) Dario-Alessandro Dornbierer co-founded Reconnect Labs (Fellow 19’) Iwan Zimmermann co-founded Linkster Therapeutics (Fellow 17’) Marcus Grüschow co-founded MGME Neurotech (Fellow 22’) Michal Beffinger co-founded InCephalo (Fellow 20’) Michal Shoshan co-founded metaLead (Fellow 23’) Dr Prajwal co-founded Clemedi (Fellow 19’) Valentina Vongrad co-founded FimmCyte (Fellow 22’) Yannick Devaud co-founded KOVE medical Ltd (Fellow 19’) 👉 Leave your vote here: https://lnkd.in/edtSvgef 💡 Learn how the Entrepreneur Fellowships support researchers to build a science-based company: https://lnkd.in/d_fkMWC #uzh #uzhinnovation #startups #translation #techtrans #prize

View organization page for UZH Innovation Hub, graphic

7,996 followers

STARTUP | Every year the @TOP 100 Swiss Startup Award showcases the 100 most-innovative and promising Swiss startups. The public voting is our chance to highlight excellent Swiss startups! Please vote for one of the following Startups by entrepreneurs from the Universität Zürich: Aimorphous Health, Aionite Capital, Blockchain Presence , BOW IT&T GmbH, CASUS Technologies, Celerato, Clemedi, cobot solutions AG, condenZero, E-VENIO, Everon AG, FimmCyte, InCephalo, Jurata, KOVE medical Ltd, LifeMatrix, Linkster Therapeutics, metaLead Therapeutics, MGME Neurotech (MGME Neurotech LLC), MUVON Therapeutics AG, Navignostics AG, PolygonSolutions GmbH, Prometheus Life Technologies, QRsens AG, Recolony AG, Reconnect Labs, tosoo ag, Vector BioPharma, VenturePole ▶️ Overview & vote: https://lnkd.in/g2vyPyRG Venturelab, UZH Alumni Picture: https://lnkd.in/gtHNyG7E

Swiss Startup Award

Swiss Startup Award

innovation.uzh.ch

To view or add a comment, sign in

Explore topics